Please contact your nearest SOBOBA Medical Weight Loss in Southern California.
In the subsequent phase III STEP trials of semaglutide, 2.4 mg once weekly, carefully up-titrated over 20 weeks, average weight losses of up to 18% were achieved over 68 weeks in people with obesity (start weight 107 kg) [40]
Tirzepatide (Mounjaro) has shown even stronger weight loss results, with an average weight loss of 15-20% in recent trials
At Vive Ageless Weight Loss Center, we offer advanced, medically supervised treatments using GLP-1 receptor agonistsFDA-approved medications that mimic your bodys natural GLP-1 hormone
Modulation of neurotransmitter secretion by GLP-1 may be another effective solution for alleviating the effects of depression
Clinical studies have shown that GLP-1 medications may help support metabolic health during the menopause transition by improving metabolic stability and supporting blood sugar control